Zhang, Zhenpo
Zheng, Jingping
Liang, Yankun
Wu, Qimin
Ding, Chufeng
Ma, Lin
Su, Ling
Article History
Received: 6 August 2024
Accepted: 25 April 2025
First Online: 9 May 2025
Declarations
:
: Not applicable. FDA Adverse Event Reporting System is a spontaneous reporting system, the publicly available data are anonymized, and therefore, obtaining consent to participate is not applicable. The present pharmacovigilance study was conducted using a public database of spontaneous reports. Given the use of deidentified data, ethical approval was not considered necessary.
: Not applicable.
: The authors declare no competing interests.